Harvard Bioscience Inc.

NASDAQ: HBIO
Share price (5/3/24): $3.82
Market cap (5/3/24): $166 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

1 Harvard Bioscience Inc. Expert Interviews, now on BamSEC.

Powered by Tegus.

Financials Filter

ended 12/31/23 FY 2023

ended 09/30/23 Q3

ended 06/30/23 Q2

ended 03/31/23 Q1

ended 12/31/22 FY 2022

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Ownership Filter

Leviticus Partners LP

Harvey Partners, LLC

Punch & Associates Investment Management, Inc.

News Filter

Material Definitive Agreement, Other Events, Financial Statements or Exhibits

Change in Directors, Officers or Compensation

Announces Fourth Quarter 2023 Financial Results

Investor Presentation

Q3 Revenues of $25.4 Million · Q3 Gross Margin of 58.1% · Q3 GAAP Operating Loss of $0.9 Million, Adjusted Operating Income $1.8 Million · Continued Strong Operating Cash Flow Drove Debt Reduction of $8.3 Million Through Q3

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Conflict Minerals disclosure